Cellosaurus A549-Mx2/EGFP L2G9 (CVCL_RX09)
Cell line name | A549-Mx2/EGFP L2G9 |
---|---|
Synonyms | A549L2G9; A549 L2G9; L2G9 |
Accession | CVCL_RX09 |
Resource Identification Initiative | To cite this cell line use: A549-Mx2/EGFP L2G9 (RRID:CVCL_RX09) |
Comments | Population: Caucasian. Biotechnology: Used for a reporter gene assay (RGA) of the human type 1 interferon potency (PubMed=27346232). Characteristics: Expression of eGFP is under the control of the control of the mouse Mx2 promoter (PubMed=27346232). Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP). Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Transposon Tn5 neo. Derived from site: In situ; Lung; UBERON=UBERON_0002048. |
Sequence variations |
|
Disease | Lung adenocarcinoma (NCIt: C3512) |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
Hierarchy | Parent: CVCL_0023 (A-549) |
Sex of cell | Male |
Age at sampling | 58Y |
Category | Cancer cell line |
Publications | PubMed=22373148; DOI=10.1186/1753-6561-5-S8-P4; PMCID=PMC3284889 PubMed=27346232; DOI=10.1016/j.jbiotec.2016.06.021 |
Cross-references | |
Cell line databases/resources | cancercelllines; CVCL_RX09 |
Encyclopedic resources | Wikidata; Q54607001 |
Entry history | |
Entry creation | 05-Mar-2018 |
Last entry update | 19-Dec-2024 |
Version number | 12 |